The short answer: real company, genuinely weak trust record
Trinity Meds is not a fake pharmacy or an outright scam — it has a disclosed corporate address, works with licensed clinicians, and names four real dispensing pharmacies. That's a real operational foundation.
But its trust signals are consistently weaker than established competitors in this space. Trustpilot scores we found range from 2.1 to 3.1 out of 5 depending on the snapshot — with one analysis citing 65% one-star reviews. There's no BBB profile at all. And in June 2026, the FDA sent a warning letter concerning the same operating entity's other brand, altRx, over misleading marketing claims. Cheap pricing is real here, but so is a meaningfully rougher record than most of the competition.
Want a stronger trust record at a comparable price?
DirectMeds offers compounded semaglutide from $249/month and tirzepatide from $397/month, with a substantially stronger and more consistent Trustpilot record.
Check eligibility at DirectMeds →Who's actually behind Trinity Meds
This is where independent reviewers have consistently flagged a real transparency problem. Trinity Meds operates through a layered corporate structure that isn't immediately clear to a new visitor: the brand name "Trinity Meds" connects to Trinity Meds, Inc. and Trinity Healthcare Supply, LLC, with a related service called CareGLP also appearing in company disclosures, alongside a separate branded site, altRx, operated by the same underlying entity.
Company materials list an operating reference address in Alpharetta, Georgia, while other listings show a registered address in Dover, Delaware — a common structure for LLCs generally (Delaware is the most common state of incorporation nationally) but one that, combined with the multiple brand names, makes it genuinely harder to pin down exactly who you're doing business with compared to competitors who present a single, clear corporate identity.
The FDA warning letter — what it actually says
On June 8, 2026, the FDA sent a warning letter concerning altrx.com — operated by the same entity behind Trinity Meds, Trinity Healthcare Supply, LLC. The letter cited two specific issues: labeling that implied altRx itself compounds the medications (according to the FDA's findings, it does not — a separate pharmacy does), and marketing language including claims like "clinically proven" applied to compounded drugs, a claim that isn't substantiated for compounded (as opposed to FDA-approved) products.
This is worth distinguishing from the broader industry story: in September 2025, the FDA sent a coordinated wave of warning letters to 55+ compounded GLP-1 marketers, including major names like Hims & Hers and DirectMeds, over standardized "same active ingredient" phrasing — an industry-wide sweep, not a unique finding against any one company. Trinity's June 2026 letter reads differently: it's specific to claims about who does the compounding and unsubstantiated efficacy language, which is a more particular finding against this specific entity rather than a shared industry pattern.
Weighing the regulatory picture before you decide?
See our full breakdown of how DirectMeds handled its own industry-wide FDA letter, and what its BBB and Trustpilot record actually shows.
Read the DirectMeds investigation →The real complaints — and why the Trustpilot number varies
We found genuine disagreement in the Trustpilot scores reported across different sources — some snapshots show 2.1/5, others closer to 3.1/5, likely reflecting different points in time as review volume grows. Rather than pick the number that makes the cleanest headline, we're presenting the honest range: roughly 2.1 to 3.1 out of 5, meaningfully weaker across every snapshot we found than most established competitors, several of which sit in the 4.0-4.6 range even with their own real complaint patterns.
The recurring complaint themes across independent reviews and Trustpilot:
- Price discrepancies — multiple reviewers report being charged more than the advertised "forever" price after signing up
- Post-cancellation charges — reports of continued billing after a patient believed they had canceled
- Charges for unapproved prescriptions — a more serious complaint category than typical billing friction, with reports of being charged before a prescription was actually approved
- Auto-renewing, all-sales-final terms — the subscription structure places the full burden on the patient to cancel exactly on time, with no stated refund path if they don't
- Inconsistent state-coverage claims — the company's FAQ states all 50 states are served, while its formal terms state coverage is limited to "certain states" without specifying which
Trinity Meds vs DirectMeds — the direct comparison
| Factor | Trinity Meds | DirectMeds |
|---|---|---|
| Semaglutide starting price | $99–159/mo (varies by promo) | $249–297/mo |
| Tirzepatide starting price | $199–259/mo | $397/mo |
| Trustpilot rating | 2.1–3.1/5 | ~4.2/5 |
| BBB profile | None found | F rating (rated, at least trackable) |
| Named compounding pharmacies | Yes — 4 named | Yes — named in our investigation |
| Corporate transparency | Multiple entities, flagged as opaque | Single entity, address disclosed |
| Most recent FDA action | June 2026 (company-specific claims) | Sept 2025 (industry-wide sweep) |
| Subscription terms | Auto-renew, reportedly all-sales-final | Standard cancellation, documented friction |
Neither company is flawless — DirectMeds carries its own real BBB F rating and its own FDA letter, which we've covered in full in our dedicated DirectMeds investigation. The honest comparison isn't "one is perfect and one is bad" — it's that Trinity Meds' problems run somewhat deeper across more categories at once: a worse and less consistent review record, zero BBB trackability at all rather than a bad rating, a more opaque corporate structure, and a company-specific (not just industry-wide) FDA finding.
Should the low price change your decision?
Trinity Meds' advertised pricing is genuinely lower than most established competitors — that part is real, not a bait-and-switch on its face. But several of the complaints specifically involve the advertised price not being honored after signup, which is exactly the scenario where a low headline number matters less than it appears to. If you're comparing purely on advertised monthly cost, Trinity Meds looks competitive. If you're comparing on the odds of the price you see being the price you actually pay, and on what happens if you need to cancel, the picture shifts meaningfully.
Want the cheapest option with a stronger track record?
DirectMeds' pricing is higher than Trinity's advertised rate, but its trust record and BBB trackability are meaningfully stronger.
Check eligibility at DirectMeds →A general checklist: how to vet any compounded GLP-1 telehealth company
This works for evaluating any company in this space, not just Trinity Meds:
- Is the corporate structure clear, or layered across multiple names? A single, clearly disclosed entity is a better sign than a brand that connects to two or three other names once you dig.
- Does the company have a trackable BBB profile at all? A bad rating is at least a rating. No profile at all means one of the standard complaint channels simply isn't available to you.
- What does the actual Trustpilot score say, checked recently? Scores can shift meaningfully as review volume grows — check current numbers directly rather than relying on any single cited figure, including this one.
- Are the cancellation terms auto-renew and all-sales-final, or standard? Read this before you enroll, not after your first charge.
- Does advertised pricing match what current customers report actually paying? "Forever" pricing that isn't honored is one of the most common complaint patterns across this entire industry, not just one company.
Our verdict
Trinity Meds is a real company with real pharmacy partnerships, not a fabricated storefront. But the trust signals that matter most — Trustpilot consistency, BBB trackability, corporate transparency, and subscription terms — are meaningfully weaker here than at established competitors, even ones that carry their own real complaint records. The advertised pricing is genuinely attractive, but several of the recurring complaints are specifically about that pricing not holding up after signup, which is the exact risk a low headline price can't protect you from.
If price is your only consideration, Trinity Meds may still make sense for you — just go in having read the cancellation terms closely and with realistic expectations about the complaint pattern. If trust record matters as much as price, DirectMeds is the stronger choice at a real, worth-it premium.
See the full DirectMeds comparison
Named pharmacies, physician-supervised, and a meaningfully stronger review and complaint record.
Check eligibility at DirectMeds →Frequently asked questions
Read the whole investigation? Here's the next step.
Compounded semaglutide from $249/month, tirzepatide from $397/month — with a meaningfully stronger trust record.
Check eligibility at DirectMeds →Sources & references
- Trustpilot. Trinitymeds.com customer review aggregate, multiple snapshots 2026.
- MalwareTips Tools. "Www.trinitymeds.com: Scam or Legit?" — corporate entity research and FDA warning letter details, June 2026.
- Zero Thought. "Trinity Meds Review 2026" — corporate structure, LegitScript/BBB status, pricing transparency findings.
- Wilson Sonsini. "FDA Sends Warning Letters to More Than 50 GLP-1 Compounders and Manufacturers." October 2025 — industry-wide context for the September 2025 warning letter sweep.
- U.S. Food & Drug Administration. Warning Letters database.
Medical disclaimer: This page is informational only and does not constitute medical advice. Individual outcomes vary. Consult a licensed physician before starting any medication.